Preliminary Outcomes of Central Responsive Neurostimulation for Multifocal Epilepsy in Pediatric Patients
View abstract on PubMed
Summary
This summary is machine-generated.Responsive neurostimulation (RNS) shows promise for pediatric drug-resistant epilepsy (DRE). This treatment led to significant seizure reduction and improved quality of life in most young patients with multifocal DRE.
Area Of Science
- Neurology
- Pediatric Epilepsy
- Neurostimulation
Background
- Drug-resistant epilepsy (DRE) presents significant challenges in pediatric patients.
- Limited surgical options exist for multifocal DRE in children.
Purpose Of The Study
- To evaluate the preliminary outcomes of centromedian responsive neurostimulation (RNS) in pediatric patients with multifocal DRE.
- To assess the safety and efficacy of RNS in this population.
Main Methods
- Retrospective chart review of 11 pediatric patients with multifocal epilepsy treated with bilateral centromedian RNS.
- Analysis of seizure reduction, subjective improvements, and complications.
Main Results
- 90% of patients achieved at least a 50% seizure reduction.
- 6 patients (55%) experienced over 75% seizure reduction.
- 8 patients (72%) reported subjective improvements in behavior and academics; 90% reported improved quality of life. No complications were observed.
Conclusions
- Centromedian RNS demonstrates a robust response and excellent safety profile in pediatric multifocal DRE.
- Neurostimulation offers a promising therapeutic option for challenging pediatric epilepsy cases.

